Methods for producing target cell reactive lymphocytes
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsPeter P. Lee, Tor B. Stuge
Life of this patent
Estimating the term…
Abstract
Methods and compositions for producing target cell reactive lymphocytes, e.g., cytolytic T-lymphocytes, in a subject are provided. In practicing the subject methods, a lymphocyte population is contacted with an effective amount of a target cell peptide mixture of active and inactive peptides to produce lymphocytes reactive, e.g., cytolytic, for the target cell. Also provided are compositions, kits, and systems for practicing the subject methods. The subject invention finds use in a variety of different applications, including therapeutic applications.
Claims1
A method of producing tumor cell-reactive T-lymphocytes, said method comprising:
- contacting a lymphocyte population with an effective amount of a peptide mixture comprising a native agonist peptide from a tumor-associated antigen, wherein the agonist peptide comprises the amino acid sequence (SEQ ID NO:1) ITDQVPSFV and an analog peptide that comprises the sequence (SEQ ID NO:2) ITAQVPSFV;
- to produce T-lymphocytes reactive for said tumor cell.
Dependencies are inferred from the claim text.